• News
  • SAN DIEGO
  • BioTech

Lumena Pharmaceuticals raises $45M in Series B financing

San Diego-based Lumena Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of novel products for rare liver diseases and serious metabolic disorders, has secured $45 million in Series B financing.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!